Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals

January 03, 2019   |   January 2019 Bond Updates
COPENHAGEN, Denmark, Jan. 2, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (NASDAQ: VELO) today announces the promotion of Mark Hensley to Chief Commercial Officer. Mr. Hensley has served as the Vice-President of Sales for Veloxis Pharmaceuticals, Inc., since May 2017, where he has...

View more at:
Related News
Home| About us | Contact us